Yutaro Kotobuki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Diagnosis and treatment in adult patients with C3 glomerulopathy in Japan: a real-world survey.
Journal: Clinical and experimental nephrology
Published: June 14, 2025
A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 19, 2022
Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial.
Journal: Journal of cardiology
Published: November 17, 2022
The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice.
Journal: Communications biology
Published: December 02, 2021
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.
Journal: BMJ open
Published: April 08, 2021
Facile synthesis and fundamental properties of an N-methylguanidine-bridged nucleic acid (GuNA[NMe]).
Journal: Organic & biomolecular chemistry
Published: August 31, 2018
Guanidine bridged nucleic acid (GuNA): an effect of a cationic bridged nucleic acid on DNA binding affinity.
Journal: Chemical communications (Cambridge, England)
Published: November 26, 2013
Synthesis and properties of thymidines with six-membered amide bridge.
Journal: Bioorganic & medicinal chemistry
Published: March 13, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026